THPO and type 2 diabetes mellitus: Interleukin-6 and thrombopoietin levels had no significant univariate effect; however, if combined with T2DM in a multivariate model, higher interleukin-6 levels had marginal effect (HR: 1.0007, 95% CI: 0.9995–1.0140, p = 0.0692) on patient survival.